Thomas Sciascia

Affiliations

  • Chief Scientific Officer at Trevi Therapeutics Inc. (TRVI), 2024-05-31
  • Svp Clin Dev & Reg Aff & Cmo at Penwest Pharmaceuticals Co (PPCO), 2010-11-08
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TRVI $2.55 53,368 214,433 2024-05-29 Filing